Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cellsKeita Shibuya, Chifumi Kitanaka, Masashi Okada et al.|Oncotarget|2014Cited by 200
JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cellsShuhei Suzuki, Chifumi Kitanaka, Masashi Okada et al.|Oncotarget|2014Cited by 94
Targeting the K-Ras - JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formationMasashi Okada, Chifumi Kitanaka, Keita Shibuya et al.|Oncotarget|2014Cited by 75
The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>Masashi Okada, Chifumi Kitanaka, Kenta Kuramoto et al.|Oncotarget|2016Cited by 60
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.Hirotsugu Sakaki, Chifumi Kitanaka, Masashi Okada et al.|PubMed|2015Cited by 55